{"id":"https://openalex.org/W2136359746","doi":null,"title":"Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.","display_name":"Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients.","publication_year":1997,"publication_date":"1997-02-01","ids":{"openalex":"https://openalex.org/W2136359746","mag":"2136359746","pmid":"https://pubmed.ncbi.nlm.nih.gov/9815678"},"language":"en","primary_location":{"id":"pmid:9815678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9815678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075048609","display_name":"Jan Gr\u00f8ndahl-Hansen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Gr\u00f8ndahl-Hansen","raw_affiliation_strings":["Finsen Laboratory, DK-2100, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Finsen Laboratory, DK-2100, Copenhagen, Denmark","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063977962","display_name":"Ib Jarle Christensen","orcid":"https://orcid.org/0000-0002-3017-7195","observed_orcids":["https://orcid.org/0000-0002-3017-7195"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I J Christensen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011403470","display_name":"Per Briand","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Briand","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064013843","display_name":"Helle Pappot","orcid":"https://orcid.org/0000-0002-3570-5372","observed_orcids":["https://orcid.org/0000-0002-3570-5372"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Pappot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017564070","display_name":"H.T. Mouridsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H T Mouridsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071906982","display_name":"M Blichert-Toft","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Blichert-Toft","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011022273","display_name":"Keld Dan\u00f8","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Dan\u00f8","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5086607557","display_name":"Nils Br\u00fcnner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Br\u00fcnner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6967,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.84348583,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"3","issue":"2","first_page":"233","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.17820000648498535,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11355","display_name":"Inflammatory Biomarkers in Disease Prognosis","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/plasminogen-activator-inhibitor-1","display_name":"plasminogen activator inhibitor-1","score":0.9850000143051147},{"id":"https://openalex.org/keywords/urokinase-type-plasminogen-activator","display_name":"urokinase","score":0.9900000095367432},{"id":"https://openalex.org/keywords/upa-receptor","display_name":"uPA receptor","score":0.7950000166893005},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7279999852180481},{"id":"https://openalex.org/keywords/low-risk-breast-cancer","display_name":"low-risk breast cancer","score":0.8569999933242798},{"id":"https://openalex.org/keywords/premenopausal-women","display_name":"premenopausal women","score":0.7749999761581421},{"id":"https://openalex.org/keywords/postmenopausal-patients","display_name":"postmenopausal patients","score":0.9919999837875366},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.8939999938011169},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C56219504","wikidata":"https://www.wikidata.org/wiki/Q7900869","display_name":"Urokinase receptor","level":3,"score":0.7997584342956543},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7902158498764038},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6859574317932129},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6520854234695435},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.6077007055282593},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.5797733664512634},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.5641941428184509},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5611866116523743},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5526431798934937},{"id":"https://openalex.org/C2778001805","wikidata":"https://www.wikidata.org/wiki/Q189961","display_name":"Mammary gland","level":4,"score":0.4996776580810547},{"id":"https://openalex.org/C2780675426","wikidata":"https://www.wikidata.org/wiki/Q410485","display_name":"Plasminogen activator inhibitor-1","level":3,"score":0.47856026887893677},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.4256511628627777},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4246244728565216},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4147421419620514},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.3670746386051178},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.14837384223937988}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D003600","descriptor_name":"Cytosol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008593","descriptor_name":"Menopause","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014568","descriptor_name":"Urokinase-Type Plasminogen Activator","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017395","descriptor_name":"Plasminogen Activator Inhibitor 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055293","descriptor_name":"Receptors, Urokinase Plasminogen Activator","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9815678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9815678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:2136359746","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9815678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W23122061","https://openalex.org/W267005183","https://openalex.org/W1485139415","https://openalex.org/W1519437906","https://openalex.org/W1558913702","https://openalex.org/W1564977527","https://openalex.org/W1569522863","https://openalex.org/W1580788756","https://openalex.org/W1589444833","https://openalex.org/W1599282089","https://openalex.org/W1964369081","https://openalex.org/W1967280348","https://openalex.org/W2034350621","https://openalex.org/W2044141048","https://openalex.org/W2091236440","https://openalex.org/W2100398674","https://openalex.org/W2114656038","https://openalex.org/W2122177826","https://openalex.org/W2123574059","https://openalex.org/W2132764202","https://openalex.org/W2145333614","https://openalex.org/W2169939433","https://openalex.org/W2200649958","https://openalex.org/W2268282843","https://openalex.org/W2415539215"],"related_works":["https://openalex.org/W2027833512","https://openalex.org/W2145333614","https://openalex.org/W2026789741","https://openalex.org/W2111924468","https://openalex.org/W2148291626","https://openalex.org/W1988630899","https://openalex.org/W2036537191","https://openalex.org/W2029837224","https://openalex.org/W2037844444","https://openalex.org/W2076243133"],"abstract_inverted_index":{"We":[0],"have":[1],"reported":[2],"previously":[3,299],"that":[4,38,225,320],"both":[5,181,331],"urokinase-type":[6],"plasminogen":[7,311],"activator":[8],"(uPA)":[9],"and":[10,34,74,85,99,107,117,133,176,191,219,262,326,333],"its":[11,71],"type":[12],"1":[13],"inhibitor":[14],"(PAI-1)":[15],"are":[16],"statistically":[17,324],"significant":[18,325],"prognostic":[19,45,67,214,229,238,304,328],"variables":[20,230],"in":[21,47,76,161,180,209,243,270,280,291,314,330],"patients":[22,52,84,89,163],"with":[23,90,157,224,246,298],"high-risk":[24,334],"breast":[25,50,77,315,335],"cancer":[26,51,78,316,336],"(Grondahl-Hansen":[27,53],"et":[28,54],"al.,":[29,55],"Cancer":[30,57],"Res.,":[31,58],"53:2513-2521,":[32],"1993),":[33],"we":[35],"recently":[36],"described":[37],"the":[39,66,122,126,141,146,210,275,292,303,309],"uPA":[40,203,286],"receptor":[41,72],"(uPAR)":[42],"is":[43,322],"a":[44,91,247,323],"marker":[46,329],"postmenopausal,":[48],"node-positive":[49],"Clin.":[56],"1:1079-1087,":[59],"1995).":[60],"The":[61,213],"present":[62],"retrospective":[63],"study":[64],"describes":[65],"impact":[68],"of":[69,94,130,143,145,216,226,249,283,306,308],"uPA,":[70,105,217],"uPAR,":[73,106,218],"PAI-1":[75,108,153,220,234,273,321],"cytosol":[79],"from":[80],"111":[81],"low-risk":[82,87],"premenopausal":[83,182,244],"184":[86],"postmenopausal":[88,162,192,271],"median":[92,123],"follow-up":[93],"6.0":[95],"years":[96],"(range,":[97,101],"3.8-14.9)":[98],"7.4":[100],"3.7-14.0)":[102],"years,":[103],"respectively.":[104],"levels":[109,142],"were":[110,119],"determined":[111],"by":[112,231],"sandwich":[113],"enzyme-linked":[114],"immunosorbent":[115],"assays,":[116],"data":[118,301],"dichotomized":[120],"using":[121],"value":[124,215],"as":[125],"cutoff":[127],"for":[128,240],"calculation":[129],"recurrence-free":[131,178,241,255],"survival":[132,160,179,242,256,264],"overall":[134,159,263],"survival.":[135],"A":[136],"correlation":[137],"was":[138,154,221,235,274],"found":[139],"between":[140],"each":[144],"three":[147],"molecules.":[148],"In":[149],"univariate":[150,211],"analysis,":[151],"high":[152],"significantly":[155],"associated":[156],"short":[158],"[relative":[164],"risk":[165],"(RR),":[166],"2.3;":[167],"95%":[168,185,195,259,267],"confidence":[169],"interval":[170],"(CI),":[171],"1.3-4.3;":[172],"P":[173,188,198],"=":[174,189,199],"0.005]":[175],"shorter":[177],"(RR,":[183,193,257,265],"2.5;":[184],"CI,":[186,196,252,260,268],"1.3-4.7;":[187],"0.004)":[190],"1.8;":[194],"1.1-2.9;":[197],"0.02)":[200],"patients.":[201,284,337],"Neither":[202,285],"nor":[204,287],"uPAR":[205,288],"reached":[206,289],"statistical":[207],"significance":[208,290,305],"analyses.":[212],"then":[222],"compared":[223],"other":[227],"established":[228],"multivariate":[232,293],"analysis.":[233,294],"an":[236],"independent":[237,277,327],"variable":[239,278],"patients,":[245,272],"RR":[248],"2.6":[250],"(95%":[251],"1.3-5.0).":[253],"For":[254],"1.9;":[258],"1.1-3.5)":[261],"2.6;":[266],"1.2-5.7)":[269],"only":[276],"left":[279],"this":[281],"group":[282],"These":[295],"data,":[296],"together":[297],"published":[300],"on":[302],"components":[307],"urokinase":[310],"activation":[312],"system":[313],"cytosols,":[317],"strongly":[318],"indicate":[319],"low-":[332]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2016-06-24T00:00:00"}